Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Company profile
Ticker
ALPMF
Exchange
Website
CEO
Kenji Yasukawa
Employees
Location
SEC CIK
IRS number
132971791
ALPMF stock data
Latest filings (excl ownership)
SC TO-T/A
Third party tender offer statement (amended)
15 Jan 20
SC TO-T/A
Third party tender offer statement (amended)
7 Jan 20
SC TO-T/A
Third party tender offer statement (amended)
30 Dec 19
SC TO-T
Third party tender offer statement
16 Dec 19
SC TO-C
Information about tender offer
9 Dec 19
SC TO-C
Information about tender offer
4 Dec 19
SC TO-C
Information about tender offer
2 Dec 19
SC TO-T/A
Third party tender offer statement (amended)
10 Feb 16
SC TO-T/A
Third party tender offer statement (amended)
25 Jan 16
SC TO-T/A
Third party tender offer statement (amended)
22 Jan 16
Transcripts